The global sulfasalazine market is estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031.
SWOT Analysis
Strength: Sulfasalazine is a highly effective treatment for rheumatoid arthritis and inflammatory bowel diseases like ulcerative colitis. It is prescribed generically and is very affordable...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian